
MSCI Inc. (MSCI)
NYSEFinancialsFinancial Data & Stock ExchangesSnapshot 2026-07-07
Reading MSCI? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MSCI free→
NYSEFinancialsFinancial Data & Stock ExchangesSnapshot 2026-07-07
Reading MSCI? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MSCI free→QuarterlyIQ Insights · MSCI
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. Current price $608.70. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $609 the market pays 34× p/e — above the 17× p/e peer median but in line with its own 35× history. That premium reflects a durable franchise our peer-anchored $595 fair value understates; treat the 'expensive vs peers' read with low confidence. Analysts target $690–$730. Note: our $595 fair value sits below the entire analyst range ($690–$730). Even valued only for durable growth at sustainable margins, it's worth about $691 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
$690.00 – $730.00 (median $700.00) · 3 analysts · as of 2026-06-18
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $700.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $617.15 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $602.91 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $134.90 | — | — | TTM | high |
| Peer P/FCF | 12M | $284.86 | 13.6 | 20.94 | TTM | high |
| Peer P/E | 12M | $295.39 | 16.5 | 17.85 | TTM | high |
| Peer P/S | 12M | $148.93 | 3.4 | 44.13 | TTM | high |
| PEG | 12M | $513.85 | 28.8 | 17.85 | TTM | high |
| Own P/E history | 12M | $631.61 | 35.4 | 17.85 | TTM | high |
| triangulated | 12M | $299.76 | 16.5 | 18.11 | Triangulated | high |
| Peer P/FCF | 3Y | $422.50 | 13.6 | 31.06 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $442.98 | 16.5 | 26.77 | Analyst | medium |
| Peer P/S | 3Y | $206.83 | 3.4 | 61.29 | Analyst | medium |
| PEG | 3Y | $770.60 | 28.8 | 26.77 | Analyst | medium |
| Own P/E history | 3Y | $947.20 | 35.4 | 26.77 | Analyst | medium |
| Peer P/FCF | 5Y | $549.50 | 13.6 | 40.39 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $548.84 | 16.5 | 33.17 | Analyst | high |
| Peer P/S | 5Y | $256.26 | 3.4 | 75.94 | Analyst | high |
| PEG | 5Y | $954.76 | 28.8 | 33.17 | Analyst | high |
| Own P/E history | 5Y | $1173.56 | 35.4 | 33.17 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.